✦ LIBER ✦

Novel agents for chronic myeloid leukemia: from imatinib to dasatinib and nilotinib: overcoming resistance

✍ Scribed by Michael W.N. Deininger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of dasatinib and nilotinib in imatin

✍ DeAngelo, Daniel J.; Attar, Eyal C. 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 324 KB

Novel targeted therapies to overcome ima

✍ Christoph Walz; Martin Sattler 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 388 KB

When Evaluating Parameter Uncertainty Is

✍ Shelby D. Reed 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Dasatinib and nilotinib in imatinib-resi

✍ Rosti, Gianantonio; Castagnetti, Fausto; Gugliotta, Gabriele; Palandri, Francesc 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 264 KB

Fasting glucose improvement under dasati

✍ M. Breccia; M. Muscaritoli; L. Cannella; C. Stefanizzi; A. Frustaci; G. Alimena 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Mutational Analysis and Overcoming Imati

✍ Michael J. Mauro 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 155 KB